IRCT20240901062926N1 IRCT 2024-09-22 Ghurki Trust Teaching Hospital The Efficacy of intra-articular shoulder injection verses combined supra scapular and axillary nerve block for adhesive capsulitis: A double-blind Randomized Control Trial AC adhesive capsulitis supra scapular nerve block SSNB axillary nerve blockAND The Efficacy of intra-articular shoulder injection verses combined supra scapular and axillary nerve block for adhesive capsulitis: A double-blind Randomized Control Trial 2024-09-05 anticipated 80 Complete https://irct.ir/trial/78811 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: N/A, Randomization description: computer-generated random numbers will be used, Blinding description: The participants in the study will not know which treatment they are receiving—whether it is the intra-articular shoulder injection or the combined suprascapular and axillary nerve block. To ensure blinding, both interventions will be performed in a manner that appears identical to the participant. For instance, both procedures will involve a similar preparation process, positioning, and the application of local anesthetic. This approach prevents participants' expectations or psychological effects from influencing the outcomes. The outcome assessor, who is responsible for evaluating the effectiveness of the treatments, will also be blinded to which intervention each participant received. This means that the assessor will not have access to information regarding the group allocation during the assessment process. Blinding the outcome assessor helps eliminate potential bias in measuring outcomes such as pain, range of motion, and functional recovery, ensuring that the results are based purely on the effects of the interventions rather than on any preconceived notions. 1 Adhesive capsulitis AC or Frozen Shoulder. Intervention 1: Intervention group: We will gather baseline measurements of shoulder discomfort, range of motion (ROM), and functional status in addition to demographic information and medical history. Next, using computer-generated random numbers in a 1:1 ratio, participants will be randomly assigned to two of three treatment groups: intra-articular shoulder injection or combination suprascapular and axillary nerve block. Participants in the combined suprascapular and axillary nerve block group will receive ultrasound-guided nerve blocks that target the corresponding nerves, while those in the intra-articular shoulder injection group will receive a Prednisolone 40mg of 1 ml corticosteroid injection directly into the glenohumeral joint. Suprascapular and axillary nerve blocks are the two forms of nerve blocks used in Group I of this experimental treatment to alleviate shoulder pain. One milliliter of 40 mg Prednisolone and two milliliters of 0.125% bupivacaine and two milliliters of lidocaine 0.125% will be mixed with five milliliters of normal saline. A total of ten milliliters solution six milliliters of solution used for the suprascapular nerve block, and four milliliters of the same substance and for the axillary nerve block. Using the combined effects of a local anesthetic and a corticosteroid to give both instant and long-lasting pain relief, both operations are guided by ultrasonography to assure accurate medication distribution. Intervention 2: Intervention group: Additionally, an intra-articular shoulder injection is used in Group II of this investigational treatment to address shoulder pain. Using a combination of a local anesthetic and a corticosteroid to reduce inflammation and give both immediate and long-lasting pain relief, the operation is guided by ultrasonography to ensure exact medicine distribution straight into the shoulder joint. An intra-articular shoulder injection is another name for this course of treatment. Yes - There is a plan to make this available What will be shared: The Efficacy of intra articular shoulder injection Verses combined suprascapular and axillary nerve block for adhesive capsulitis: A double blind Randomized Control Trial When: 20th January 2025 and so on To whom: to the journal while publishing the data Conditions: Journal can access to the data after publishing Where to obtain: To obtain the necessary documents or data files, the applicant should contact the organization directly. The preferred method of communication is via email, which allows for a quick and efficient response. Applicants can also reach out by telephone for urgent inquiries, or by postal mail if a formal request is required. For online requests, visiting the organization's website and following specific procedures is recommended. How to obtain: To obtain data files from Ghurki Hospital, the applicant should follow a few steps. Prepare a formal request detailing the data needed. The preferred method of communication is via email, as it typically offers a quicker response time, ranging from a few hours to a few days. If submitting the request via postal mail, account for additional time due to delivery and internal processing, which can extend the timeline by several weeks. Ghurki Hospital may also offer an online portal for document requests, which is usually the fastest option, providing immediate confirmation and estimated processing times. After submission, the hospital may require further information, such as proof of identity, additional forms, or a processing fee, which could add a few more days to the process. Once approved, the documents or data files will typically be sent via email or through a secure download link. If physical copies are needed, these will be sent by postal mail, with additional time required for delivery. Overall, expect the process to take from one to several weeks, so it’s advisable to start the request well in advance of any deadlines. Comments: we are planning to publish it in reputed journal for better clinical practice and EBP